schliessen

Filtern

 

Bibliotheken

7.

Evaluating the contribution of rare variants to type 2 diabetes and related traits using pedigrees.
by Jun, Goo

Proceedings of the National Academy of Sciences of the United States of America, January 9, 2018, Vol.115(2), pp.379-384

10.

Genetic Risk Reclassification for Type 2 Diabetes by Age Below or Above 50 Years Using 40 Type 2 Diabetes Risk Single Nucleotide Polymorphisms
by De Miguel-Yanes, Jose M.

de Miguel-Yanes, Jose M., Peter Shrader, Michael J. Pencina, Caroline S. Fox, Alisa K. Manning, Richard W. Grant, Josèe Dupuis, et al. 2011. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 34(1): 121-125.

11.

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
by Jaiswal, Siddhartha

The New England Journal of Medicine, 25 December 2014, Vol.371(26), pp.2488-2498

18.

The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH): Design of a pharmacogenetic Resource for Type 2 Diabetes
by Walford, Geoffrey A.

Walford, G. A., N. Colomo, J. N. Todd, L. K. Billings, M. Fernandez, B. Chamarthi, A. S. Warner, et al. 2015. “The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH): Design of a pharmacogenetic Resource for Type 2 Diabetes.” PLoS ONE 10 (3): e0121553. doi:10.1371/journal.pone.0121553. http://dx.doi.org/10.1371/journal.pone.0121553.

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 125 Hits